Bank of New York Mellon Corp - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,893,541
-82.2%
307,610
-67.6%
0.00%
-75.0%
Q2 2023$38,653,429
-17.3%
950,416
-1.5%
0.01%
-20.0%
Q1 2023$46,759,437
+25.1%
965,306
-1.5%
0.01%
+11.1%
Q4 2022$37,388,126
-26.6%
979,516
-3.5%
0.01%
-25.0%
Q3 2022$50,967,000
+25.0%
1,015,294
-0.3%
0.01%
+33.3%
Q2 2022$40,777,000
+2.5%
1,017,870
-4.6%
0.01%
+12.5%
Q1 2022$39,787,000
-10.5%
1,066,395
-4.5%
0.01%0.0%
Q4 2021$44,468,000
-2.4%
1,116,476
-8.8%
0.01%
-11.1%
Q3 2021$45,553,000
-11.3%
1,224,227
+0.8%
0.01%
-10.0%
Q2 2021$51,339,000
+34.7%
1,214,597
+50.9%
0.01%
+25.0%
Q1 2021$38,125,000
-19.4%
805,161
+3.8%
0.01%
-20.0%
Q4 2020$47,327,000
+36.1%
775,472
+4.2%
0.01%
+11.1%
Q3 2020$34,786,000
-7.9%
744,087
-0.0%
0.01%
-10.0%
Q2 2020$37,770,000
+144.2%
744,378
+114.7%
0.01%
+100.0%
Q1 2020$15,464,000
+0.9%
346,647
+8.6%
0.01%
+25.0%
Q4 2019$15,327,000
+47.7%
319,120
+4.0%
0.00%
+33.3%
Q3 2019$10,375,000
-25.5%
306,757
-0.8%
0.00%
-25.0%
Q2 2019$13,918,000
+22.6%
309,296
+2.5%
0.00%
+33.3%
Q1 2019$11,356,000
+28.3%
301,704
+16.9%
0.00%0.0%
Q4 2018$8,854,000
-2.4%
258,004
+33.7%
0.00%
+50.0%
Q3 2018$9,068,000
+44.6%
192,943
+3.8%
0.00%0.0%
Q2 2018$6,269,000
+29.3%
185,830
+3.7%
0.00%
+100.0%
Q1 2018$4,850,000
+62.3%
179,230
+0.0%
0.00%0.0%
Q4 2017$2,989,000
-12.9%
179,170
+4.5%
0.00%0.0%
Q3 2017$3,431,000
+15.5%
171,477
+5.8%
0.00%0.0%
Q2 2017$2,970,000
+65.7%
162,008
-11.0%
0.00%
Q1 2017$1,792,000
+1.5%
182,048
+12.4%
0.00%
-100.0%
Q4 2016$1,766,000
-24.6%
161,925
-3.1%
0.00%0.0%
Q3 2016$2,342,000
+122.4%
167,144
+11.4%
0.00%
Q2 2016$1,053,000
+12.7%
150,068
+3.5%
0.00%
Q1 2016$934,000
-80.8%
145,024
-3.7%
0.00%
-100.0%
Q4 2015$4,877,000
+26.4%
150,521
+4.2%
0.00%0.0%
Q3 2015$3,857,000
-50.5%
144,466
-10.8%
0.00%
-50.0%
Q2 2015$7,791,000
-7.8%
161,875
+16.6%
0.00%0.0%
Q1 2015$8,450,000
+10.1%
138,866
-6.3%
0.00%0.0%
Q4 2014$7,673,000
+22.6%
148,215
+4.2%
0.00%0.0%
Q3 2014$6,257,000
-14.7%
142,177
-49.4%
0.00%
+100.0%
Q2 2014$7,338,000
+428.3%
280,762
+428.5%
0.00%
Q1 2014$1,389,000
+100.4%
53,120
+29.9%
0.00%
Q4 2013$693,000
-36.8%
40,880
-20.0%
0.00%
Q3 2013$1,096,00051,1140.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
AXON CAPITAL LP 216,200$9,729,00020.31%
GREAT POINT PARTNERS LLC 1,974,385$88,847,000,0009.86%
RTW INVESTMENTS, LP 3,137,361$141,181,0007.54%
Asymmetry Capital Management, L.P. 280,542$12,624,0006.84%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 259,000$11,642,0004.32%
Boxer Capital, LLC 1,000,000$45,000,0003.87%
Opaleye Management Inc. 226,388$10,187,0003.10%
SECTORAL ASSET MANAGEMENT INC 450,638$20,279,0002.42%
SCOPIA CAPITAL MANAGEMENT LP 983,005$44,235,0001.96%
Chubb Ltd 8,180$368,0001.82%
View complete list of PTC THERAPEUTICS INC shareholders